Article
Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients.
Journal of diabetes investigation - 1 Aug 2021
Yamakage Hajime, Konishi Yousuke, Muranaka Kazuya, Hotta Kikuko, Miyamoto Yoshihiro, Morisaki Hiroko, Morisaki Takayuki, Satoh-Asahara Noriko
Abstract excerpt
AIMS/INTRODUCTION: Weight reduction therapy is the primary treatment to prevent complications of obesity, such as lifestyle diseases and cardiovascular disease; however, to date, useful methods and genetic factors for predicting the outcomes of weight reduction therapy in obese patients have not been established. Protein tyrosine phosphatase 1B (PTP1B), a negative regulator for insulin and leptin signaling,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
